Citius Oncology Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 05/15/2026 | 9.19 M | $5.70 M | 64.55% | 9.19% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 3.84 M | $2.37 M | 1,792,030.84% | 3.83% |
| 05/15/2026 | 534.82 K | $331.59 K | 100.00% | 0.53% | |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 264.73 K | $164.11 K | 20.31% | 0.26% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 121.91 K | $75.58 K | 100.00% | 0.12% |
| IFP ADVISORS, INC | 04/13/2026 | 107.42 K | $66.59 K | 22.88% | 0.11% |
| BLACKROCK, INC. | 05/13/2026 | 47.45 K | $29.42 K | 112.38% | 0.05% |
| NORTHERN TRUST CORP | 05/14/2026 | 45.75 K | $28.36 K | 0.00% | 0.05% |
| STATE STREET CORP | 05/15/2026 | 42.90 K | $26.59 K | 0.00% | 0.04% |
| UBS GROUP AG | 05/05/2026 | 36.84 K | $22.84 K | 71.64% | 0.04% |
| ARKADIOS WEALTH ADVISORS | 05/18/2026 | 11.67 K | $7.23 K | 0.00% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 10.13 K | $6.28 K | -11.38% | 0.01% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 05/11/2026 | 1 | $1 | 100.00% | 0.00% |
| OMERS ADMINISTRATION CORP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| VERSANT CAPITAL MANAGEMENT, INC | 04/07/2026 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 04/07/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Citius Oncology Inc. institutional Ownership - FAQ's
During the previous two years, 19 institutional investors and hedge funds held shares of Citius Oncology Inc.. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 9.19 M
BANK OF AMERICA CORP /DE/: 3.84 M
GEODE CAPITAL MANAGEMENT, LLC: 264,733
VANGUARD FIDUCIARY TRUST CO: 121,910
IFP Advisors, Inc: 107,424
BlackRock, Inc.: 47,454
14.24% of Citius Oncology Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 14.31 M shares in the last 24 months. This purchase volume represents approximately $14.45 M in transactions.